| Aug 19 |
US DoD grants $2.3m to Immuron for military version of anti-diarrhoeal Travelan
|
| Aug 16 |
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
|
| Aug 7 |
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
|
| Jul 17 |
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
|
| Jul 15 |
Immuron announces record Travelan® sales globally, Australia and USA
|
| Jul 2 |
Immuron requests pre-IND meeting for IMM-529 with FDA filing
|
| Jun 12 |
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
|
| Jun 5 |
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
|
| May 31 |
Immuron CEO Steven Lydeamore to present at Peak Sky High
|
| May 31 |
Immuron Board Changes
|
